Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-2.63M.
ENTERPRISE VALUE (EV)
$-2.63M
Soligenix, Inc.
Market Cap
$5.31M
Enterprise Value (EV)
$-2.63M
Market Cap
$5.62M
Enterprise Value (EV)
$3.57M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Soligenix, Inc. (SNGX) | $5.31M | $-2.63M |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.29M | $3.12M |
| Pulmatrix, Inc. (PULM)vs › | $5.28M | $3.11M |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.23M | $8.64M |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | $3.47M |
| Alzamend Neuro Inc (ALZN)vs › | $5.20M | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.59M | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.07M | $11.70M |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.62M | $3.57M |
| Imunon, Inc. (IMNN)vs › | $5.06M | $6.04M |
Market Cap
$5.31M
Total Debt
$0.00
Cash
$7.94M
Enterprise Value
$-2.63M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
